Home Cart Sign in  
Chemical Structure| 2983-37-1 Chemical Structure| 2983-37-1

Structure of Ethyl 2-ethylhexanoate
CAS No.: 2983-37-1

Chemical Structure| 2983-37-1

Ethyl 2-ethylhexanoate

CAS No.: 2983-37-1

4.5 *For Research Use Only !

Cat. No.: A305480 Purity: 95%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łËǶÊÊ Inquiry Inquiry
1g ł§Ê¶ÊÊ Inquiry Inquiry
5g łóó¶ÊÊ Inquiry Inquiry
25g łËËʶÊÊ Inquiry Inquiry
100g łÿďʶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 250mg

    łËǶÊÊ

  • 1g

    ł§Ê¶ÊÊ

  • 5g

    łóó¶ÊÊ

  • 25g

    łËËʶÊÊ

  • 100g

    łÿďʶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Obringer, Cindy ; Lester, Cathy ; Karb, Michael ; Smith, Alex ; Ellison, Corie A. ;

Abstract: Fatty esters of 2-ethylhexanoic acid (EHA) and 2-ethylhexanol (EH) are commonly used in cosmetics. Human liver and skin S9 and human plasma were used to determine the in vitro rates of clearance (CLint) of a series of compounds, with a range of 2-11 carbons on the acid or alc. moiety and branching at the C2 position. The impact of carbon chain length on in vitro CLint was most prominent for the liver metabolism of esters of EH, while for in vitro skin metabolism it was greater for esters of EHA. The position of the branching also impacted the liver hydrolysis rates, especially for the C3, C4, and C5 esters with lower CLint in vitro rates for esters of EHA relative to those of EH. When the in vitro intrinsic clearance rates were scaled to in vivo rates of hepatic clearance, all compounds approximated the rate for hepatic blood flow, mitigating this dependence of metabolism on structure. This work shows how structural changes to the mol. can affect in vitro metabolism and, furthermore, allows for an estimation of the in vivo metabolism

Keywords: Alkyl fatty esters ; Ester metabolism ; Liver ; Skin ; Plasma ; Clearance ; IVIVE

Purchased from AmBeed:

Alternative Products

Product Details of [ 2983-37-1 ]

CAS No. :2983-37-1
Formula : C10H20O2
M.W : 172.27
SMILES Code : CCCCC(CC)C(=O)OCC
MDL No. :MFCD00462678
InChI Key :YXAGIRHBJJLWHW-UHFFFAOYSA-N
Pubchem ID :102916

Safety of [ 2983-37-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 2983-37-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 0
Fraction Csp3 0.9
Num. rotatable bonds 7
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 51.47
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.3 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.98
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.33
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.77
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.58
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.61
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.85

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.54
Solubility 0.492 mg/ml ; 0.00286 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.56
Solubility 0.0476 mg/ml ; 0.000276 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.8
Solubility 0.274 mg/ml ; 0.00159 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-4.99 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.38
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 2983-37-1 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 19074-24-9

A113513 [19074-24-9]

Bis(2-ethylhexyl) dodecanedioate

Similarity: 0.96

Chemical Structure| 22047-49-0

A377025 [22047-49-0]

2-Ethylhexyl stearate

Similarity: 0.96

Chemical Structure| 7452-79-1

A272052 [7452-79-1]

Ethyl 2-methylbutanoate

Similarity: 0.96

Chemical Structure| 1187-74-2

A180630 [1187-74-2]

Diethyl 2-(2-oxopropyl)succinate

Similarity: 0.93

Chemical Structure| 6138-26-7

A178230 [6138-26-7]

Trimethyl propane-1,2,3-tricarboxylate

Similarity: 0.93

Esters

Chemical Structure| 20417-61-2

A121721 [20417-61-2]

Ethyl 2-formylcyclopropanecarboxylate

Similarity: 0.96

Chemical Structure| 104802-52-0

A135937 [104802-52-0]

trans-Ethyl 4-(hydroxymethyl)cyclohexanecarboxylate

Similarity: 0.96

Chemical Structure| 710-43-0

A142085 [710-43-0]

cis-Diethyl cyclopropane-1,2-dicarboxylate

Similarity: 0.96

Chemical Structure| 175415-95-9

A142169 [175415-95-9]

(1S,2S)-2-(Ethoxycarbonyl)cyclopropanecarboxylic acid

Similarity: 0.96

Chemical Structure| 166412-78-8

A157854 [166412-78-8]

Bis(7-methyloctyl) cyclohexane-1,2-dicarboxylate

Similarity: 0.96